Professor | Weimin Yu | Asia Growth Partners

	Upload Avatar (500 x 500)
Name	Weimin Yu
Contact Information	1025931346@qq.com
Language ability	English, Chinese
Province	Hubei

Upload Avatar (500 x 500)

Name

Weimin Yu

Contact Information

1025931346@qq.com

Language ability

English, Chinese

Province

Hubei

University/Lab Affiliation and Title	Wuhan University
Faculty	Medical School
Academic Background & Achievements	2008.7–2011.6 Doctorate in Surgery: Wuhan University 2005.9–2008.6 Master's in Surgery: Wuhan University 2000.9–2005.6 Bachelor in Clinical Medicine: Wuhan University First and second prizes in Hubei Province Science and Technology Progress Published over 50 academic papers, including more than 30 SCI indexed papers
Work Experience	2020.6 to present - Wuhan University, Renmin Hospital, Chief Physician in Urology 2016.8-2017.8 - University of California, Davis Comprehensive Cancer Center, Visiting Scholar 2015.12-2020.6 - Wuhan University, Renmin Hospital, Associate Chief Physician in Urology 2014.10-2014.12 - Fukushima Medical University, Visiting Scholar in Urology 2012.12-2015.12 - Wuhan University, Renmin Hospital, Attending Physician in Urology 2011.7-2012.12 - Wuhan University, Renmin Hospital, Resident Physician in Urology
Awards	2023.12 First Prize for Technological Advancement in Hubei Province: Key Techniques and Clinical Application of Minimally Invasive Treatment for Kidney Stones 2017.12 Second Prize for Technological Advancement in Hubei Province: Clinical Technique Improvement Based on Hidden Penis Impact on Corpora Cavernosa Structure and Function

University/Lab Affiliation and Title

Wuhan University

Faculty

Medical School

Academic Background & Achievements

2008.7–2011.6 Doctorate in Surgery: Wuhan University
2005.9–2008.6 Master's in Surgery: Wuhan University
2000.9–2005.6 Bachelor in Clinical Medicine: Wuhan University
First and second prizes in Hubei Province Science and Technology Progress
Published over 50 academic papers, including more than 30 SCI indexed papers

Work Experience

2020.6 to present - Wuhan University, Renmin Hospital, Chief Physician in Urology
2016.8-2017.8 - University of California, Davis Comprehensive Cancer Center, Visiting Scholar
2015.12-2020.6 - Wuhan University, Renmin Hospital, Associate Chief Physician in Urology
2014.10-2014.12 - Fukushima Medical University, Visiting Scholar in Urology
2012.12-2015.12 - Wuhan University, Renmin Hospital, Attending Physician in Urology
2011.7-2012.12 - Wuhan University, Renmin Hospital, Resident Physician in Urology

Awards

2023.12 First Prize for Technological Advancement in Hubei Province: Key Techniques and Clinical Application of Minimally Invasive Treatment for Kidney Stones
2017.12 Second Prize for Technological Advancement in Hubei Province: Clinical Technique Improvement Based on Hidden Penis Impact on Corpora Cavernosa Structure and Function

Areas of Focus	Bladder urothelial cancer cell biology Tumor microenvironment and immunotherapy Mechanism of acute pressure perfusion injury in hydronephrosis
Publications	Presence of a Novel Anatomical Structure May Cause Bleeding When Using the Calyx Access in Mini-Percutaneous Nephrolithotomy, Fangyou Lin, Bojun Li, Ting Rao, Yuan Ruan, Weimin Yu, Fan Cheng, Stéphane Larré, 2022 TFAP2C Knockdown Sensitizes Bladder Cancer Cells to Cisplatin Treatment via Regulation of EGFR and NF-Κb, Ji Xing, Wu Chen, Kang Chen, Shaoming Zhu, Fangyou Lin, Yucheng Qi, Yunlong Zhang, Shangting Han, Ting Rao, Yuan Ruan, Sheng Zhao, Weimin Yu, Fan Cheng, 2022 Tubular cell-derived exosomal miR-150-5p contributes to renal fibrosis following unilateral ischemia-reperfusion injury by activating fibroblast in vitro and in vivo, Zhou X, Zhao S, Li W, Ruan Y, Yuan R, Ning J, Jiang K, Xie J, Yao X, Li H, Li C, Rao T, Yu W, Cheng F, 2021 Photobiomodulation With Blue Laser Inhibits Bladder Cancer Progression, Xia Y, Yu W, Cheng F, Rao T, Ruan Y, Yuan R, Ning J, Zhou X, Lin F, Zheng D, 2021 Experience in management of emergency and severe cases of non-COVID-19 during the outbreak of COVID-19, Yu W, Ruan Y, Ning J, Cheng F, 2021 Novel lncRNA XLOC_032768 protects against renal tubular epithelial cells apoptosis in renal ischemia–reperfusion injury by regulating FNDC3B/TGF-β1, Zhou X, Li Y, Wu C, Yu W, Cheng F, 2020 Traditional Classification and Novel Subtyping Systems for Bladder Cancer, Zhu S, Yu W, Yang X, Wu C, Cheng F, 2020 Novel lncRNA XLOC_032768 alleviates cisplatin-induced apoptosis and inflammatory response of renal tubular epithelial cells through TNF-α, Zhou X, Jiang K, Luo H, Wu C, Yu W, Cheng F, 2020 MiR-425 Promotes Migration and Invasion in Bladder Cancer by Targeting Dickkopf 3, Ning JZ, Yu WM, Cheng F, Rao T, Ruan Y, 2020

Areas of Focus

Bladder urothelial cancer cell biology
Tumor microenvironment and immunotherapy
Mechanism of acute pressure perfusion injury in hydronephrosis

Publications

Presence of a Novel Anatomical Structure May Cause Bleeding When Using the Calyx Access in Mini-Percutaneous Nephrolithotomy, Fangyou Lin, Bojun Li, Ting Rao, Yuan Ruan, Weimin Yu, Fan Cheng, Stéphane Larré, 2022
TFAP2C Knockdown Sensitizes Bladder Cancer Cells to Cisplatin Treatment via Regulation of EGFR and NF-Κb, Ji Xing, Wu Chen, Kang Chen, Shaoming Zhu, Fangyou Lin, Yucheng Qi, Yunlong Zhang, Shangting Han, Ting Rao, Yuan Ruan, Sheng Zhao, Weimin Yu, Fan Cheng, 2022
Tubular cell-derived exosomal miR-150-5p contributes to renal fibrosis following unilateral ischemia-reperfusion injury by activating fibroblast in vitro and in vivo, Zhou X, Zhao S, Li W, Ruan Y, Yuan R, Ning J, Jiang K, Xie J, Yao X, Li H, Li C, Rao T, Yu W, Cheng F, 2021
Photobiomodulation With Blue Laser Inhibits Bladder Cancer Progression, Xia Y, Yu W, Cheng F, Rao T, Ruan Y, Yuan R, Ning J, Zhou X, Lin F, Zheng D, 2021
Experience in management of emergency and severe cases of non-COVID-19 during the outbreak of COVID-19, Yu W, Ruan Y, Ning J, Cheng F, 2021
Novel lncRNA XLOC_032768 protects against renal tubular epithelial cells apoptosis in renal ischemia–reperfusion injury by regulating FNDC3B/TGF-β1, Zhou X, Li Y, Wu C, Yu W, Cheng F, 2020
Traditional Classification and Novel Subtyping Systems for Bladder Cancer, Zhu S, Yu W, Yang X, Wu C, Cheng F, 2020
Novel lncRNA XLOC_032768 alleviates cisplatin-induced apoptosis and inflammatory response of renal tubular epithelial cells through TNF-α, Zhou X, Jiang K, Luo H, Wu C, Yu W, Cheng F, 2020
MiR-425 Promotes Migration and Invasion in Bladder Cancer by Targeting Dickkopf 3, Ning JZ, Yu WM, Cheng F, Rao T, Ruan Y, 2020

Bladder Cancer Urothelial Cells Cell Biology Tumor Microenvironment Immunotherapy Hydronephrosis Acute Injury Pressure Perfusion Cellular Mechanisms Clinical Research

Xing Huang - Wuhan University

Haijun Yu - Wuhan University

Fan Cheng - Wuhan University

View All

Personal Information

Academic Information

Research

Contact us

No account yet?

Personal Information

Academic Information

Research

Contact us